Unilateral Posterior Uveitis in a Patient Receiving Nivolumab for Malignant Melanoma

Patients using immunotherapies like immune checkpoint inhibitors (ICIs) can develop ocular immune-related adverse effects (irAEs). Nivolumab (Opdivo(®);Bristol-Myers Squibb, New York, NY, USA) is a commonly used ICI used to treat malignancies. A 75-year-old woman presented to our eye clinic with sud...

Descripción completa

Detalles Bibliográficos
Autores principales: Giannakis, Periklis, Malik, Mohsan, Rashid, Sukaina, Vrizidou, Eleni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492902/
https://www.ncbi.nlm.nih.gov/pubmed/37700996
http://dx.doi.org/10.7759/cureus.43311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492902/
https://www.ncbi.nlm.nih.gov/pubmed/37700996
http://dx.doi.org/10.7759/cureus.43311

Ejemplares similares